Top Markets
#1 MowCat MowCat +779.42%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.88%
#3 Akedo Akedo +53.14%
#4 Magma Finance Magma Finance +43.48%
#5 SIXSEVEN SIXSEVEN +30.64%
#6 DeXe DeXe +29.84%
#7 MarsCoin MarsCoin +29.20%
#8 Cortex Cortex +26.39%
#9 Pons Pons +15.85%
#10 Nillion Nillion +13.67%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rank in Stocks #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Share Price
$25.61
Last synced: 2025-10-10
Market Cap
$1.37B
Change (1 day)
0.20%
Change (1 year)
1.59%
Country
US
Trade Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Category

Healthcare
Earnings for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Earnings in 2026 TTM: 0
According to Harrow Health, Inc. 8.625% Senior Notes due 2026 latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Harrow Health, Inc. 8.625% Senior Notes due 2026 from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT